Truist Securities Daily Spotlight

研报英文原文证据摘录

Truist Securities Daily Spotlight

shape on the back of increased power demand. We maintain

Buy but lower our NAV-based PT to $65 from $74 on a mark to

market in commodity prices and discount rate. While the near-

term remains less encouraging, we believe EQT is set up well

to take advantage of incremental natural gas demand (10-20

Bcf/d by 2030 depending on the scenario) driven by AI/data

centers. LNG supply agreements beginning in 2030 - 2031 further

augment EQT's competitive position. On the call, look for details

on incremental GSA's, and growth expectations heading into '27.

- Gabe Daoud

Financials

Banks - US BANKS: Model Mods - We update seven bank

models following recent conferences and catch-ups with

management. The changes are generally small nips and tucks to

align with updated points of guidance. - Brian Foran

Healthcare

AdaptHealth Corp. (AHCO, $9.70, Buy) - AHCO - Management

Meeting Takeaways, Reiterate Buy - We remain bullish on

AHCO post management meetings highlighting solid core trends,

continued headway on the sizable recent capitated contract

coupled with a wide range of growth/efficiency opportunities.

We expect ongoing progress on labor cost normalization around

the contract, see further opportunity/expect additional capitated

wins over time, and expect technology investment to help drive

additional benefits around efficiency and for patients/payers/

providers. We continue to view AHCO’s scale/breadth of the

offering and national footprint as key differentiators further

underpinned by solid FCF/attractive financial flexibility. Reiterate

Buy and $14 price target. - David MacDonald

argenx SE (ARGX, $853.40, Buy) - ARGX - Oh My-Myositis!

New Subset-Specific Analysis Strategy Unveiled at R&D Day -